相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibitors of PARP: Number crunching and structure gazing
Johannes Rudolph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Progress and outlook in studying the substrate specificities of PARPs and related enzymes
Marcin J. Suskiewicz et al.
FEBS JOURNAL (2021)
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs
Jeffrey W. Johannes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
The BRCT domain of PARP1 binds intact DNA and mediates intrastrand transfer
Johannes Rudolph et al.
MOLECULAR CELL (2021)
HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones
Fa-Hui Sun et al.
NATURE COMMUNICATIONS (2021)
Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs
Johannes Rudolph et al.
NATURE COMMUNICATIONS (2021)
HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase
Johannes Rudolph et al.
ELIFE (2021)
Serine-linked PARP1 auto-modification controls PARP inhibitor response
Evgeniia Prokhorova et al.
NATURE COMMUNICATIONS (2021)
HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation
Marcin J. Suskiewicz et al.
NATURE (2020)
Probing the Conformational Changes Associated with DNA Binding to PARP1
Johannes Rudolph et al.
BIOCHEMISTRY (2020)
The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy-Current progress and future direction
Yue Zhao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nicola J. Curtin et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
A structure-kinetic relationship study using matched molecular pair analysis
Doris A. Schuetz et al.
RSC MEDICINAL CHEMISTRY (2020)
PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow
Todd A. Hopkins et al.
MOLECULAR CANCER RESEARCH (2019)
PARP family enzymes: regulation and catalysis of the poly(ADP-ribose) posttranslational modification
Marie-France Langelier et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)
Specificity of reversible ADP-ribosylation and regulation of cellular processes
Kerryanne Crawford et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity
Ian Gibbs-Seymour et al.
MOLECULAR CELL (2016)
Mechanistic Dissection of PARP1 Trapping and the Impacton In Vivo Tolerability and Efficacy of PARP Inhibitors
Todd A. Hopkins et al.
MOLECULAR CANCER RESEARCH (2015)
Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance
Peter Bai
MOLECULAR CELL (2015)
PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain
Jennine M. Dawicki-McKenna et al.
MOLECULAR CELL (2015)
BMN673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency
Yuqiao Shen et al.
CLINICAL CANCER RESEARCH (2013)
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
Bryan A. Gibson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Structural Basis for DNA Damage-Dependent Poly(ADP-ribosyl)ation by Human PARP-1
Marie-France Langelier et al.
SCIENCE (2012)
The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
Thomas Helleday
MOLECULAR ONCOLOGY (2011)
Targeting homologous recombination repair defects in cancer
Bastiaan Evers et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide:: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer
Thomas D. Penning et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one: A Novel Bioavailable Inhibitor of Poly(ADP-ribose) Polymerase-1
Keith A. Menear et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
ABT-888, an orallyactive poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models
Cherrie K. Donawho et al.
CLINICAL CANCER RESEARCH (2007)
Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial
Huw D. Thomas et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Cancer susceptibility and the functions of BRCA1 and BRCA2
AR Venkitaraman
CELL (2002)
In search of the tumour-suppressor functions of BRCA1 and BRCA2
R Scully et al.
NATURE (2000)
分享论文
